[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Europe Meningococcal Vaccines Market Report 2016

November 2016 | 100 pages | ID: EC8727FD94DEN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Meningococcal Vaccines

Revenue, means the sales value of Meningococcal Vaccines

This report studies sales (consumption) of Meningococcal Vaccines in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
  • GlaxoSmithKline
  • Sanofi Pasteur
  • Merck
  • Novartis
  • Pfizer
  • bioCSL (Seqirus)
  • Protein Sciences
Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Meningococcal Vaccines in these countries, from 2011 to 2021 (forecast), like
  • Germany
  • France
  • UK
  • Russia
  • Italy
  • Spain
  • Benelux
Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Type I
  • Type II
  • Type III
Split by application, this report focuses on sales, market share and growth rate of Meningococcal Vaccines in each application, can be divided into
  • Application 1
  • Application 2
  • Application 3
Europe Meningococcal Vaccines Market Report 2016

1 MENINGOCOCCAL VACCINES OVERVIEW

1.1 Product Overview and Scope of Meningococcal Vaccines
1.2 Classification of Meningococcal Vaccines
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Meningococcal Vaccines
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Meningococcal Vaccines Market by Countries
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Russia Status and Prospect (2011-2021)
  1.4.5 Italy Status and Prospect (2011-2021)
  1.4.6 Spain Status and Prospect (2011-2021)
  1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Meningococcal Vaccines (2011-2021)
  1.5.1 Europe Meningococcal Vaccines Sales and Growth Rate (2011-2021)
  1.5.2 Europe Meningococcal Vaccines Revenue and Growth Rate (2011-2021)

2 EUROPE MENINGOCOCCAL VACCINES BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Meningococcal Vaccines Market Competition by Manufacturers
  2.1.1 Europe Meningococcal Vaccines Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Meningococcal Vaccines Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Meningococcal Vaccines (Volume and Value) by Type
  2.2.1 Europe Meningococcal Vaccines Sales and Market Share by Type (2011-2016)
  2.2.2 Europe Meningococcal Vaccines Revenue and Market Share by Type (2011-2016)
2.3 Europe Meningococcal Vaccines (Volume and Value) by Countries
  2.3.1 Europe Meningococcal Vaccines Sales and Market Share by Countries (2011-2016)
  2.3.2 Europe Meningococcal Vaccines Revenue and Market Share by Countries (2011-2016)
2.4 Europe Meningococcal Vaccines (Volume) by Application

3 GERMANY MENINGOCOCCAL VACCINES (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Meningococcal Vaccines Sales and Value (2011-2016)
  3.1.1 Germany Meningococcal Vaccines Sales and Growth Rate (2011-2016)
  3.1.2 Germany Meningococcal Vaccines Revenue and Growth Rate (2011-2016)
  3.1.3 Germany Meningococcal Vaccines Sales Price Trend (2011-2016)
3.2 Germany Meningococcal Vaccines Sales and Market Share by Manufacturers
3.3 Germany Meningococcal Vaccines Sales and Market Share by Type
3.4 Germany Meningococcal Vaccines Sales and Market Share by Application

4 FRANCE MENINGOCOCCAL VACCINES (VOLUME, VALUE AND SALES PRICE)

4.1 France Meningococcal Vaccines Sales and Value (2011-2016)
  4.1.1 France Meningococcal Vaccines Sales and Growth Rate (2011-2016)
  4.1.2 France Meningococcal Vaccines Revenue and Growth Rate (2011-2016)
  4.1.4 France Meningococcal Vaccines Sales Price Trend (2011-2016)
4.2 France Meningococcal Vaccines Sales and Market Share by Manufacturers
4.3 France Meningococcal Vaccines Sales and Market Share by Type
4.4 France Meningococcal Vaccines Sales and Market Share by Application

5 UK MENINGOCOCCAL VACCINES (VOLUME, VALUE AND SALES PRICE)

5.1 UK Meningococcal Vaccines Sales and Value (2011-2016)
  5.1.1 UK Meningococcal Vaccines Sales and Growth Rate (2011-2016)
  5.1.2 UK Meningococcal Vaccines Revenue and Growth Rate (2011-2016)
  5.1.5 UK Meningococcal Vaccines Sales Price Trend (2011-2016)
5.2 UK Meningococcal Vaccines Sales and Market Share by Manufacturers
5.3 UK Meningococcal Vaccines Sales and Market Share by Type
5.4 UK Meningococcal Vaccines Sales and Market Share by Application

6 RUSSIA MENINGOCOCCAL VACCINES (VOLUME, VALUE AND SALES PRICE)

6.1 Russia Meningococcal Vaccines Sales and Value (2011-2016)
  6.1.1 Russia Meningococcal Vaccines Sales and Growth Rate (2011-2016)
  6.1.2 Russia Meningococcal Vaccines Revenue and Growth Rate (2011-2016)
  6.1.6 Russia Meningococcal Vaccines Sales Price Trend (2011-2016)
6.2 Russia Meningococcal Vaccines Sales and Market Share by Manufacturers
6.3 Russia Meningococcal Vaccines Sales and Market Share by Type
6.4 Russia Meningococcal Vaccines Sales and Market Share by Application

7 ITALY MENINGOCOCCAL VACCINES (VOLUME, VALUE AND SALES PRICE)

7.1 Italy Meningococcal Vaccines Sales and Value (2011-2016)
  7.1.1 Italy Meningococcal Vaccines Sales and Growth Rate (2011-2016)
  7.1.2 Italy Meningococcal Vaccines Revenue and Growth Rate (2011-2016)
  7.1.7 Italy Meningococcal Vaccines Sales Price Trend (2011-2016)
7.2 Italy Meningococcal Vaccines Sales and Market Share by Manufacturers
7.3 Italy Meningococcal Vaccines Sales and Market Share by Type
7.4 Italy Meningococcal Vaccines Sales and Market Share by Application

8 SPAIN MENINGOCOCCAL VACCINES (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Meningococcal Vaccines Sales and Value (2011-2016)
  8.1.1 Spain Meningococcal Vaccines Sales and Growth Rate (2011-2016)
  8.1.2 Spain Meningococcal Vaccines Revenue and Growth Rate (2011-2016)
  8.1.8 Spain Meningococcal Vaccines Sales Price Trend (2011-2016)
8.2 Spain Meningococcal Vaccines Sales and Market Share by Manufacturers
8.3 Spain Meningococcal Vaccines Sales and Market Share by Type
8.4 Spain Meningococcal Vaccines Sales and Market Share by Application

9 BENELUX MENINGOCOCCAL VACCINES (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux Meningococcal Vaccines Sales and Value (2011-2016)
  9.1.1 Benelux Meningococcal Vaccines Sales and Growth Rate (2011-2016)
  9.1.2 Benelux Meningococcal Vaccines Revenue and Growth Rate (2011-2016)
  9.1.9 Benelux Meningococcal Vaccines Sales Price Trend (2011-2016)
9.2 Benelux Meningococcal Vaccines Sales and Market Share by Manufacturers
9.3 Benelux Meningococcal Vaccines Sales and Market Share by Type
9.4 Benelux Meningococcal Vaccines Sales and Market Share by Application

10 EUROPE MENINGOCOCCAL VACCINES MANUFACTURERS ANALYSIS

10.1 GlaxoSmithKline
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Meningococcal Vaccines Product Type, Application and Specification
    10.1.2.1 Type I
    10.1.2.2 Type II
  10.1.3 GlaxoSmithKline Meningococcal Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  10.1.4 Main Business/Business Overview
10.2 Sanofi Pasteur
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Meningococcal Vaccines Product Type, Application and Specification
    10.2.2.1 Type I
    10.2.2.2 Type II
  10.2.3 Sanofi Pasteur Meningococcal Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  10.2.4 Main Business/Business Overview
10.3 Merck
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Meningococcal Vaccines Product Type, Application and Specification
    10.3.2.1 Type I
    10.3.2.2 Type II
  10.3.3 Merck Meningococcal Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  10.3.4 Main Business/Business Overview
10.4 Novartis
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Meningococcal Vaccines Product Type, Application and Specification
    10.4.2.1 Type I
    10.4.2.2 Type II
  10.4.3 Novartis Meningococcal Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  10.4.4 Main Business/Business Overview
10.5 Pfizer
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Meningococcal Vaccines Product Type, Application and Specification
    10.5.2.1 Type I
    10.5.2.2 Type II
  10.5.3 Pfizer Meningococcal Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  10.5.4 Main Business/Business Overview
10.6 bioCSL (Seqirus)
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Meningococcal Vaccines Product Type, Application and Specification
    10.6.2.1 Type I
    10.6.2.2 Type II
  10.6.3 bioCSL (Seqirus) Meningococcal Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  10.6.4 Main Business/Business Overview
10.7 Protein Sciences
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Meningococcal Vaccines Product Type, Application and Specification
    10.7.2.1 Type I
    10.7.2.2 Type II
  10.7.3 Protein Sciences Meningococcal Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  10.7.4 Main Business/Business Overview

11 MENINGOCOCCAL VACCINES MANUFACTURING COST ANALYSIS

11.1 Meningococcal Vaccines Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Meningococcal Vaccines

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Meningococcal Vaccines Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Meningococcal Vaccines Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE MENINGOCOCCAL VACCINES MARKET FORECAST (2016-2021)

14.1 Germany Meningococcal Vaccines Sales Forecast (2016-2021)
14.2 France Meningococcal Vaccines Sales Forecast (2016-2021)
14.3 UK Meningococcal Vaccines Sales Forecast (2016-2021)
14.4 Russia Meningococcal Vaccines Sales Forecast (2016-2021)
14.5 Italy Meningococcal Vaccines Sales Forecast (2016-2021)
14.6 Spain Meningococcal Vaccines Sales Forecast (2016-2021)
14.7 Benelux Meningococcal Vaccines Sales Forecast (2016-2021)
14.8 Europe Meningococcal Vaccines Sales Forecast by Type (2016-2021)
14.9 Europe Meningococcal Vaccines Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Meningococcal Vaccines
Table Classification of Meningococcal Vaccines
Figure Europe Sales Market Share of Meningococcal Vaccines by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Meningococcal Vaccines
Figure Europe Sales Market Share of Meningococcal Vaccines by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Meningococcal Vaccines Revenue and Growth Rate (2011-2021)
Figure France Meningococcal Vaccines Revenue and Growth Rate (2011-2021)
Figure UK Meningococcal Vaccines Revenue and Growth Rate (2011-2021)
Figure Russia Meningococcal Vaccines Revenue and Growth Rate (2011-2021)
Figure Italy Meningococcal Vaccines Revenue and Growth Rate (2011-2021)
Figure Spain Meningococcal Vaccines Revenue and Growth Rate (2011-2021)
Figure Benelux Meningococcal Vaccines Revenue and Growth Rate (2011-2021)
Figure Europe Meningococcal Vaccines Sales and Growth Rate (2011-2021)
Figure Europe Meningococcal Vaccines Revenue and Growth Rate (2011-2021)
Table Europe Meningococcal Vaccines Sales of Key Manufacturers (2015 and 2016)
Table Europe Meningococcal Vaccines Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Meningococcal Vaccines Sales Share by Manufacturers
Figure 2016 Meningococcal Vaccines Sales Share by Manufacturers
Table Europe Meningococcal Vaccines Revenue by Manufacturers (2015 and 2016)
Table Europe Meningococcal Vaccines Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Meningococcal Vaccines Revenue Share by Manufacturers
Table 2016 Europe Meningococcal Vaccines Revenue Share by Manufacturers
Table Europe Meningococcal Vaccines Sales and Market Share by Type (2011-2016)
Table Europe Meningococcal Vaccines Sales Share by Type (2011-2016)
Figure Sales Market Share of Meningococcal Vaccines by Type (2011-2016)
Figure Europe Meningococcal Vaccines Sales Growth Rate by Type (2011-2016)
Table Europe Meningococcal Vaccines Revenue and Market Share by Type (2011-2016)
Table Europe Meningococcal Vaccines Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Meningococcal Vaccines by Type (2011-2016)
Figure Europe Meningococcal Vaccines Revenue Growth Rate by Type (2011-2016)
Table Europe Meningococcal Vaccines Sales and Market Share by Countries (2011-2016)
Table Europe Meningococcal Vaccines Sales Share by Countries (2011-2016)
Figure Sales Market Share of Meningococcal Vaccines by Countries (2011-2016)
Table Europe Meningococcal Vaccines Revenue and Market Share by Countries (2011-2016)
Table Europe Meningococcal Vaccines Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Meningococcal Vaccines by Countries (2011-2016)
Table Europe Meningococcal Vaccines Sales and Market Share by Application (2011-2016)
Table Europe Meningococcal Vaccines Sales Share by Application (2011-2016)
Figure Sales Market Share of Meningococcal Vaccines by Application (2011-2016)
Figure Germany Meningococcal Vaccines Sales and Growth Rate (2011-2016)
Figure Germany Meningococcal Vaccines Revenue and Growth Rate (2011-2016)
Figure Germany Meningococcal Vaccines Sales Price Trend (2011-2016)
Table Germany Meningococcal Vaccines Sales by Manufacturers (2015 and 2016)
Table Germany Meningococcal Vaccines Market Share by Manufacturers (2015 and 2016)
Table Germany Meningococcal Vaccines Sales by Type (2015 and 2016)
Table Germany Meningococcal Vaccines Market Share by Type (2015 and 2016)
Table Germany Meningococcal Vaccines Sales by Application (2015 and 2016)
Table Germany Meningococcal Vaccines Market Share by Application (2015 and 2016)
Figure France Meningococcal Vaccines Sales and Growth Rate (2011-2016)
Figure France Meningococcal Vaccines Revenue and Growth Rate (2011-2016)
Figure France Meningococcal Vaccines Sales Price Trend (2011-2016)
Table France Meningococcal Vaccines Sales by Manufacturers (2015 and 2016)
Table France Meningococcal Vaccines Market Share by Manufacturers (2015 and 2016)
Table France Meningococcal Vaccines Sales by Type (2015 and 2016)
Table France Meningococcal Vaccines Market Share by Type (2015 and 2016)
Table France Meningococcal Vaccines Sales by Application (2015 and 2016)
Table France Meningococcal Vaccines Market Share by Application (2015 and 2016)
Figure UK Meningococcal Vaccines Sales and Growth Rate (2011-2016)
Figure UK Meningococcal Vaccines Revenue and Growth Rate (2011-2016)
Figure UK Meningococcal Vaccines Sales Price Trend (2011-2016)
Table UK Meningococcal Vaccines Sales by Manufacturers (2015 and 2016)
Table UK Meningococcal Vaccines Market Share by Manufacturers (2015 and 2016)
Table UK Meningococcal Vaccines Sales by Type (2015 and 2016)
Table UK Meningococcal Vaccines Market Share by Type (2015 and 2016)
Table UK Meningococcal Vaccines Sales by Application (2015 and 2016)
Table UK Meningococcal Vaccines Market Share by Application (2015 and 2016)
Figure Russia Meningococcal Vaccines Sales and Growth Rate (2011-2016)
Figure Russia Meningococcal Vaccines Revenue and Growth Rate (2011-2016)
Figure Russia Meningococcal Vaccines Sales Price Trend (2011-2016)
Table Russia Meningococcal Vaccines Sales by Manufacturers (2015 and 2016)
Table Russia Meningococcal Vaccines Market Share by Manufacturers (2015 and 2016)
Table Russia Meningococcal Vaccines Sales by Type (2015 and 2016)
Table Russia Meningococcal Vaccines Market Share by Type (2015 and 2016)
Table Russia Meningococcal Vaccines Sales by Application (2015 and 2016)
Table Russia Meningococcal Vaccines Market Share by Application (2015 and 2016)
Figure Italy Meningococcal Vaccines Sales and Growth Rate (2011-2016)
Figure Italy Meningococcal Vaccines Revenue and Growth Rate (2011-2016)
Figure Italy Meningococcal Vaccines Sales Price Trend (2011-2016)
Table Italy Meningococcal Vaccines Sales by Manufacturers (2015 and 2016)
Table Italy Meningococcal Vaccines Market Share by Manufacturers (2015 and 2016)
Table Italy Meningococcal Vaccines Sales by Type (2015 and 2016)
Table Italy Meningococcal Vaccines Market Share by Type (2015 and 2016)
Table Italy Meningococcal Vaccines Sales by Application (2015 and 2016)
Table Italy Meningococcal Vaccines Market Share by Application (2015 and 2016)
Figure Spain Meningococcal Vaccines Sales and Growth Rate (2011-2016)
Figure Spain Meningococcal Vaccines Revenue and Growth Rate (2011-2016)
Figure Spain Meningococcal Vaccines Sales Price Trend (2011-2016)
Table Spain Meningococcal Vaccines Sales by Manufacturers (2015 and 2016)
Table Spain Meningococcal Vaccines Market Share by Manufacturers (2015 and 2016)
Table Spain Meningococcal Vaccines Sales by Type (2015 and 2016)
Table Spain Meningococcal Vaccines Market Share by Type (2015 and 2016)
Table Spain Meningococcal Vaccines Sales by Application (2015 and 2016)
Table Spain Meningococcal Vaccines Market Share by Application (2015 and 2016)
Figure Benelux Meningococcal Vaccines Sales and Growth Rate (2011-2016)
Figure Benelux Meningococcal Vaccines Revenue and Growth Rate (2011-2016)
Figure Benelux Meningococcal Vaccines Sales Price Trend (2011-2016)
Table Benelux Meningococcal Vaccines Sales by Manufacturers (2015 and 2016)
Table Benelux Meningococcal Vaccines Market Share by Manufacturers (2015 and 2016)
Table Benelux Meningococcal Vaccines Sales by Type (2015 and 2016)
Table Benelux Meningococcal Vaccines Market Share by Type (2015 and 2016)
Table Benelux Meningococcal Vaccines Sales by Application (2015 and 2016)
Table Benelux Meningococcal Vaccines Market Share by Application (2015 and 2016)
Table Meningococcal Vaccines Basic Information List
Table GlaxoSmithKline Meningococcal Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline Meningococcal Vaccines Sales Market Share (2011-2016)
Table Sanofi Pasteur Basic Information List
Table Sanofi Pasteur Meningococcal Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Pasteur Meningococcal Vaccines Sales Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Meningococcal Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Meningococcal Vaccines Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Meningococcal Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Meningococcal Vaccines Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Meningococcal Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Meningococcal Vaccines Sales Market Share (2011-2016)
Table bioCSL (Seqirus) Basic Information List
Table bioCSL (Seqirus) Meningococcal Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table bioCSL (Seqirus) Meningococcal Vaccines Sales Market Share (2011-2016)
Table Protein Sciences Basic Information List
Table Protein Sciences Meningococcal Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Protein Sciences Meningococcal Vaccines Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Meningococcal Vaccines
Figure Manufacturing Process Analysis of Meningococcal Vaccines
Figure Meningococcal Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Meningococcal Vaccines Major Manufacturers in 2015
Table Major Buyers of Meningococcal Vaccines
Table Distributors/Traders List
Figure Germany Meningococcal Vaccines Sales and Growth Rate Forecast (2016-2021)
Figure Germany Meningococcal Vaccines Revenue and Growth Rate Forecast (2016-2021)
Figure France Meningococcal Vaccines Sales and Growth Rate Forecast (2016-2021)
Figure France Meningococcal Vaccines Revenue and Growth Rate Forecast (2016-2021)
Figure UK Meningococcal Vaccines Sales and Growth Rate Forecast (2016-2021)
Figure UK Meningococcal Vaccines Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Meningococcal Vaccines Sales and Growth Rate Forecast (2016-2021)
Figure Russia Meningococcal Vaccines Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Meningococcal Vaccines Sales and Growth Rate Forecast (2016-2021)
Figure Italy Meningococcal Vaccines Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Meningococcal Vaccines Sales and Growth Rate Forecast (2016-2021)
Figure Spain Meningococcal Vaccines Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Meningococcal Vaccines Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Meningococcal Vaccines Revenue and Growth Rate Forecast (2016-2021)
Table Europe Meningococcal Vaccines Sales Forecast by Type (2016-2021)
Table Europe Meningococcal Vaccines Sales Forecast by Application (2016-2021 )


More Publications